Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Arsenic Exposure, Disordered Glucose Homeostasis and Atherosclerosis Protocol

NCT02759289 is registered in ClinicalTrials.gov with NYU Langone Health as lead sponsor.

NCT NCT02759289
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02759289 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Arsenic Exposure, Disordered Glucose Homeostasis and Atherosclerosis Protocol
Lead sponsor
NYU Langone Health
Phase
Observational
Overall status
Completed
Start date
November 30, 2015
Completion date
September 15, 2020
Enrollment
279 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atherosclerosis, type 2 diabetes (t2d)